Evidence map›Paper›PMID 39553671›Full record

ArticleHeliyon2024

Evaluating a German learning disorders platform using the RE-AIM framework.

Lior Weinreich, Gido Metz, Björn Witzel, Olga Hermansson, Paula Dümig, Gerd Schulte-Körne, Kristina Moll

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lior WeinreichDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nussbaumstrasse 5, 80336, Munich, Germany.
Gido MetzCare and Public Health Research Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University, Universiteitssingel 40, 6229 ER, Maastricht, the Netherlands.
Björn WitzelDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nussbaumstrasse 5, 80336, Munich, Germany.
Olga HermanssonDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nussbaumstrasse 5, 80336, Munich, Germany.
Paula DümigDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nussbaumstrasse 5, 80336, Munich, Germany.
Gerd Schulte-KörneDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nussbaumstrasse 5, 80336, Munich, Germany.
Kristina MollDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nussbaumstrasse 5, 80336, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, online platforms have made educational, medical, and other professional content easily accessible, but research evaluating such platforms is still scarce. The purpose of the current study is to evaluate LONDI, a German learning disorders platform. The platform offers scientifically based information for different user groups, and an algorithm-based help system that professionals can use to facilitate diagnosing and planning interventions. The evaluation is focused on the user group of learning therapists using the platform and its help system. It is theoretically grounded on the RE-AIM framework and assesses four of its dimensions: Reach, Adoption, Implementation and Maintenance. Results from an online questionnaire (

Indexed as

Learning disordersMatomo analyticsOnline platform evaluationUser experience

Identifiers

PMID39553671
PMCPMC11566692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.